LifeStance Health Group, Inc. (LFST) 当前追踪市盈率 (P/E) 为 259.5, 前瞻市盈率为 89.1. 追踪盈利收益率为 0.39%, 前瞻盈利收益率 1.12%. PEG 0.34 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $1.49.
本页证实的标准:
SharesGrow 综合评分： 59/100 其中 2/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2019 | 1,443.4 | 0.00 | -49.19 | 38.50 | - |
| 2020 | -214.9 | 0.04 | 8.20 | 21.69 | - |
| 2021 | -10.1 | -0.38 | 2.02 | 4.67 | - |
| 2022 | -8.1 | 0.19 | 1.16 | 2.04 | - |
| 2023 | -15.4 | 0.94 | 2.01 | 2.73 | - |
| 2024 | -48.6 | 0.69 | 1.93 | 2.23 | - |
| 2025 | 281.2 | -2.34 | 1.79 | 1.91 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2019 | $0.02 | $212.52M | $5.67M | 2.7% |
| 2020 | $-0.10 | $377.22M | $-38.07M | -10.1% |
| 2021 | $-0.94 | $667.51M | $-307.2M | -46% |
| 2022 | $-0.61 | $859.54M | $-215.56M | -25.1% |
| 2023 | $-0.51 | $1.06B | $-186.26M | -17.6% |
| 2024 | $-0.15 | $1.25B | $-57.44M | -4.6% |
| 2025 | $0.02 | $1.42B | $9.66M | 0.7% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $0.07 | $0.06 – $0.08 | $1.64B | $1.62B – $1.65B | 4 |
| 2027 | $0.14 | $0.13 – $0.15 | $1.87B | $1.86B – $1.89B | 4 |
| 2028 | $0.33 | $0.22 – $0.40 | $2.13B | $2.13B – $2.13B | 4 |
